Company: NDRA
Filing Date: 2025-10-28
Form Type: DEF 14A
Source: 0001654954-25-012254
Chunk: 40

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-28
Form: DEF 14A
Chunk 40
---
 was $194,776 for 2024, and the compensation for our former PEO was $157,105, $452,050 and $443,594 for 2024, 2023 and 2022, respectively. The average of the amounts of compensation actually paid to our Non-PEO NEOs as a group (excluding Mr. Michelon), as computed in accordance with Item 402(v) of Regulation S-K, was $90,026, $266,365 and $315,373 for 2024, 2023 and 2022, respectively. The Company’s net income, as computed in accordance with Item 402(v) of Regulation S-K and reflected in the Company’s audited financial statements for the applicable year, was $(11.5), $(10.1), and $(13.2) million for 2024, 2023 and 2022 respectively.

| 29 |

The chart below shows the relationship between the compensation actually paid to our current PEO, former PEO and non-PEO NEOs to the Company’s net loss over the three years.

CAP Table Compared to Cumulative TSR

|            |     | PEO |         |     | Average non-PEO NEOs |         |     | Investment Value |       |
|:-----------|:----|:----|--------:|:----|:---------------------|--------:|:----|:-----------------|------:|
| 12/31/2022 |     |     | 443,594 |     |                      | 315,373 |     | $                | 27.13 |
| 12/31/2023 |     |     | 452,050 |     |                      | 266,339 |     | $                | 14.13 |
| 12/31/2024 |     |     | 194,776 |     |                      |  98,026 |     |                  |     - |

| 30 |

<div align='center'>PROPOSAL 3 -RATIFICATION OF APPOINTMENT OF

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>

The Audit Committee of the Board of Directors has appointed RBSM LLP (“RBSM”) as our independent registered public accounting firm for the fiscal year ending December 31, 2025. We are presenting this selection to our stockholders for ratification at the 2025 Annual Meeting.

RBSM audited our financial statements